The S&P 500 snapped a five-month winning streak in August as a rise in U.S. Treasury yields weighed on shares of heavyweight growth stocks such as Apple and Microsoft , whose future cash flows are discounted more with a rise in rates.
J&J unveiled the first outlook for its standalone drugs and medical device businesses late last month after completing the spinoff of its consumer health company Kenvue.